Showing results (81-90 of 639) with videos related to

Sort By:
Pageof 64
Cancer Cell|January 18, 2020
One or Two Immune Checkpoint Inhibitors?Caroline Robert, Emilie Lanoy, Benjamin Besse
Presse Medicale (Paris, France : 1983)|March 23, 2011
[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment]Julien Hadoux, Benjamin Besse, David Planchard
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|October 7, 2021
The efficacy of immune checkpoint inhibitors in thoracic malignanciesJordi Remon, Francesco Facchinetti, Benjamin Besse
Bulletin Du Cancer|November 8, 2012
[Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France]Julien Hadoux, Nicolas Girard, Benjamin Besse
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2005
Chemoprevention of lung cancerStéphane Vignot, Jean-Philippe Spano, Sylvie Lantuejoul, et al.
Critical Reviews in Oncology/Hematology|February 14, 2006
Telomeres and telomerase as targets for anticancer drug developmentKen André Olaussen, Karine Dubrana, Julien Domont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Vulvar Carcinoma: Standard of Care and PerspectivesCyrus Chargari, Johanna Wasserman, Alexandra Gabro, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Tomorrow's targeted therapies in breast cancer patients: what is the risk for increased radiation-induced cardiac toxicity?Nicolas Magné, Cyrus Chargari, Dhara MacDermed, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Pageof 64